High-dose busulfan and cyclophosphamide as a conditioning regimen for autologous peripheral blood stem cell transplantation in childhood non-hodgkin lymphoma patients: A long-term follow-up study

Journal of Pediatric Hematology/Oncology

Volumn 33, Issue 3, 2011, Pages

  Andion, Maitane ^a   Molina, Blanca ^a   Gonzalez Vicent, Marta ^a   Alonso, Laura ^a   Hernandez, Carmen ^a   Lassaletta, Alvaro ^a   Lopez Ibor, Blanca ^b   Villa, Marta ^b   Diaz, Miguel Angel ^a,b  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^b Hospital Madrid Monteprincipe   (Spain)

Author keywords

autologous SCT; busulfan and cyclophosphamide; children; high dose chemotherapy; non Hodgkin lymphoma

Indexed keywords

ANTIEMETIC AGENT; BUSULFAN; CLONAZEPAM; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; URSODEOXYCHOLIC ACID;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; BURKITT LYMPHOMA; CHILD; CLINICAL ARTICLE; CRYOPRESERVATION; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEPATIC SINUSOIDAL OBSTRUCTION SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MALE; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; OBSTRUCTION; PRESCHOOL CHILD; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SEIZURE; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENCE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 79954414462     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181fd6c79     Document Type: Article

References (19)

1. Gross TG, Hale GA, He W, et al. Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents. Biol Blood Marrow Transplant. 2010;16:223-230.
2. Kim JG, Sohn SK, Chae YS, et al. Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant. 2007;40:919-924. (Pubitemid 350048188)
3. Aggarwal C, Gupta S, Vaughan WP, et al. Improved outcomes in intermediate- and high-risk aggressive non-Hodgkin lymphoma after autologous hematopoietic stem cell transplantation substituting intravenous for oral busulfan in a busulfan, cyclophosphamide, and etoposide preparative regimen. Biol Blood Marrow Transplant. 2006;12:770-777. (Pubitemid 43899416)
4. Ulrickson M, Aldridge J, Kim HT, et al. Busulfan and cyclophosphamide (Bu/Cy) as a preparative regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma: a single-institution experience. Biol Blood Marrow Transplant. 2009;15:1447-1454.
5. Kröger N, Hoffknecht M, Hänel M, et al. Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy. Bone Marrow Transplant. 1998;21:1171-1175. (Pubitemid 28318741)
6. Gutierrez-Delgado F, Maloney DG, Press OW, et al. Autologous stem cell transplantation for non-Hodgkińs lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens. Bone Marrow Transplant. 2001;28:455-461. (Pubitemid 33072077)
7. Hänel M, Kröger N, Sonnenberg S, et al. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma. Ann hematol. 2002;81:96-102. (Pubitemid 36067583)
8. Escalón MP, Stefanovic A, Venkatraman A, et al. Autologous transplantation for relapsed non-Hodgkińs lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience. Bone Marrow Transplant. 2009;44:89-96.
9. Bradley MB, Cairo MS. Stem cell transplantation for pediatric lymphoma: past, present and future. Bone Marrow Transplant. 2008;41:149-158. (Pubitemid 351188912)
10. Diaz MA, Villa M, Alegre A, et al. Collection and transplantation of peripheral blood progenitor cells mobilized by G-CSF alone in children with malignancies. Br J Hematol. 1996;94:148-154. (Pubitemid 26232557)
11. Diaz MA, Alegre A, Villa M, et al. Pediatric experience with autologous peripheral blood progenitor cell transplantation: influence of CD34+ cell dose in engraftment kinetics. Bone Marrow Transplant. 1996;18:699-703. (Pubitemid 26361356)
12. + cell count predicts progenitor cell yield. Haematologica. 1999;84:30-33.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
14. Won SC, Han JW, Kwon SY, et al. Autologous peripheral blood stem cell transplantation in children with non-Hodgkińs lymphoma: a report from the Korean Society of Pediatric Hematology-Oncology. Ann Hematol. 2006;85:787-794. (Pubitemid 44377876)
15. Woessmann W, Peters C, Lenhard M, et al. Allogeneic hematopoietic stem cell transplantation in relapsed or refractory anaplastia large cell lymphoma of children and adolescents. A Berlin-Frankfurt-Münster group report. Br J Hematol. 2006;133:176-182.
16. Levine JE, Harris RE, Loberiza FR, et al. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood. 2003;101:2476-2482. (Pubitemid 36857601)
17. Gopal AK, Gooley TA, Golden JB, et al. Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkińs lymphoma in adults 60 years of age and older. Bone Marrow Transplant. 2001;27:593-599. (Pubitemid 32401456)
18. Shah AJ, Lenarsky C, Kapoor N, et al. Busulfan and cyclophosphamide as a conditioning regimen for pediatric acute lymphoblastic leukemia patients undergoing bone marrow transplantation. J Pediatr hematol Oncol. 2004;26:91-97. (Pubitemid 38186262)
19. Yusuf RZ, Dey B, Yeap BY, et al. Autologous SCT with a dose-reduced Bu and Cy regimen in older patients with non-Hodgkin lymphoma. Bone Marrow Transplant. 2009;43:37-42.